Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications Article

Dolores Lopez-Lucas, Maria, Pachon-Pena, Gisela, Maria Garcia-Hernandez, Ana et al. (2018). Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications . 20(9), 1110-1123. 10.1016/j.jcyt.2018.07.001

International Collaboration

cited authors

  • Dolores Lopez-Lucas, Maria; Pachon-Pena, Gisela; Maria Garcia-Hernandez, Ana; Parrado, Antonio; Sanchez-Salinas, Dario; Garcia-Bernal, David; Del Carmen Alguero, Maria; Iniesta Martinez, Francisca; Blanquer, Miguel; Cabanas-Perianes, Valentin; Molina-Molina, Mar; Asin-Aguilar, Cira; Moraleda, Jose M; Sackstein, Robert

fiu authors

publication date

  • September 1, 2018

keywords

  • Biotechnology & Applied Microbiology
  • CORD BLOOD
  • Cell & Tissue Engineering
  • Cell Biology
  • E-selectin ligand
  • FETAL BOVINE SERUM
  • HCELL
  • HEMATOPOIETIC TISSUES
  • HUMAN BONE-MARROW
  • Hematology
  • IN-VITRO
  • L-SELECTIN LIGAND
  • Life Sciences & Biomedicine
  • Medicine, Research & Experimental
  • PLATELET LYSATE
  • PRECURSOR CELLS
  • PROGENITOR CELLS
  • Research & Experimental Medicine
  • STEM-CELLS
  • Science & Technology
  • exofucosylation
  • fucosyltransferase
  • glycosyltransferase programmed stereosubstitution
  • good manufacturing practice
  • hematopoietic cell E-IL-selectin ligand
  • mesenchymal stem cell
  • sialyl Lewis X

Digital Object Identifier (DOI)

start page

  • 1110

end page

  • 1123

volume

  • 20

issue

  • 9